Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04062123 · ClinicalTrials.gov registry record · Phase 1
Memory & Conditioning Under Anesthesia
A Phase 1 study, sponsored by Keith M Vogt.
- Completed
- Registry status
- Phase 1
- Development phase
- 92
- Enrollment target
NCT04062123: Completed Phase 1 study, sponsored by Keith M Vogt.
NCT04062123 is a Phase 1 study that has completed, run by Keith M Vogt. The registered enrollment target is 92 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (53% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04062123, a Phase 1 study, has completed, sponsored by Keith M Vogt.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 92 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effects of pain on long-term memory and conditioned physiologic responses in the presence and absence of distinct intravenous anesthetics. Functional magnetic resonance imaging will be used to identify the neural correlates of these phenomena The study will occur over 5 visits and involves no long-term follow up.
Primary Outcome
Recognition memory testing, using the Remember-Know procedure, in which subjects indicate whether they recognize previously experienced experimental items among novel items (not previously in the experiment). This allows calculation of interdependent measures of recollection \& familiarity using the signal detection statistic, d'. d' is calculated as the cumulative Gaussian distribution of false positive responses subtracted from the cumulative Gaussian distribution of correctly identified previ
Interventions
- DRUG Placebo
- DRUG Dexmedetomidine
- DRUG Propofol
- DEVICE Peripheral Nerve Stimulation
- DRUG Fentanyl
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2020-07-30 |
| Est. Completion | 2024-04-22 |
| Phase | Phase 1 |
What the finished NCT04062123 record still lists
NCT04062123 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 92 participants, a relatively small participant target, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (53% higher).
The record links to 0 conditions, and to 5 interventions - of which Placebo is the first listed.
NCT04062123 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04062123 about?
NCT04062123 is a clinical study titled "Memory & Conditioning Under Anesthesia". The purpose of this study is to determine the effects of pain on long-term memory and conditioned physiologic responses in the presence and absence of distinct intravenous anesthetics. Functional magnetic resonance imaging will be used to identify the neural correlates of these phenomena The study w...
What is the current status of trial NCT04062123?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 92 participants. The study started on 2020-07-30. Estimated completion is 2024-04-22.
What interventions are being tested in trial NCT04062123?
The interventions under investigation include: Placebo (DRUG), Dexmedetomidine (DRUG), Propofol (DRUG), Peripheral Nerve Stimulation (DEVICE), Fentanyl (DRUG).
Who is sponsoring clinical trial NCT04062123?
This trial is sponsored by Keith M Vogt, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04062123's enrollment target sits among peer trials
92 625th of 2000 higher than 1,375 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03184545 · 92 participants · Phase 3
Comparing the Outcome of Electrical Stimulation and Physical Therapy in Patellofemoral Pain Syndrome
- NCT04172532 · 92 participants · Phase 1
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
- NCT04508088 · 92 participants
Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease
- NCT04840602 · 92 participants · Phase 2
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI